Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Background Episodes of depression are the most frequent cause of disability among patients with bipolar disorder. The effectiveness and safety of standard antidepressant agents for depressive episodes associated with bipolar disorder (bipolar depression) have not been well studied. Our study was designed to determine whether adjunctive antidepressant therapy reduces symptoms of bipolar depression without increasing the risk of mania. Methods In this double-blind, placebo-controlled study, we randomly assigned subjects with bipolar depression to receive up to 26 weeks of treatment with a mood stabilizer plus adjunctive antidepressant therapy or a mood stabilizer plus a matching placebo, under conditions generalizable to routine clinical care. A standardized clinical monitoring form adapted from the mood-disorder modules of the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, was used at all follow-up visits. The primary outcome was the percentage of subjects in each treatment group meeting the criterion for a durable recovery (8 consecutive weeks of euthymia). Secondary effectiveness outcomes and rates of treatment-emergent affective switch (a switch to mania or hypomania early in the course of treatment) were also examined. Results Forty-two of the 179 subjects (23.5%) receiving a mood stabilizer plus adjunctive antidepressant therapy had a durable recovery, as did 51 of the 187 subjects (27.3%) receiving a mood stab…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Based on negative placebo‐controlled data, we do not recommend paroxetine (level 2 negative).245”
In the citing paper
“Antimanic medications reduce depressive symptoms in only one-third of patients (2).”
From Adjunctive Bright Light Therapy for Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Trial (2018) · cites this paper as [2]
Citations
Cites
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
The mini international neuropsychiatric interview
Lecrubier, Y., Sheehan, D., Hergueta, T., & Weiller, E. (1998) · European Psychiatry · doi:10.1016/s0924-9338(99)80239-9 · Cited by 5,872
The Structured Clinical Interview for DSM-III-R (SCID): I: History, Rationale, and Description
Spitzer, R. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080032005 · Cited by 4,336
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
Prevalence and Treatment of Mental Disorders, 1990 to 2003
Kessler, R. C., Demler, O., Frank, R. G., Olfson, M., Pincus, H. A., Walters, E. E., Wang, P., Wells, K. B., & Zaslavsky, A. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa043266 · Cited by 1,910
Extending Indications for Long-Term Pharmacotherapy: Opportunities and Challenges
Kane, J. M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.1 · Cited by 987
Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Self-citationPerlis, R. H., Ostacher, M. J., Patel, J. K., Marangell, L. B., Zhang, H., Wisniewski, S. R., Ketter, T. A., Miklowitz, D. J., Otto, M. W., Gyulai, L., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.217 · Cited by 689
Self-citationPrevalence and Treatment of Mental Disorders
(2005) · New England Journal of Medicine · doi:10.1056/nejmc051936 · Cited by 650
Research works printed but not linked: 4
- Murray CJ, 1994, Bull World Health Organ, 72, 495
- Sheehan DV, 1998, J Clin Psychiatry, 59, 22
- Sachs GS, 1994, J Clin Psychiatry, 55, 391
- 10.1037/0021-843X.108.4.579 · doi:10.1037/0021-843x.108.4.579 · Paper page
Cited by
Items 901–935 of 935
(2025) · Wiley eBooks · doi:10.1002/9781119870203.mpg002.pub2
Antidepressant Remission and Manic Switch in Bipolar Depression: A Propensity Score Analysis
Vöhringer, P. A., Barroilhet, S. A., Palma, B. A., & Perlis, R. H. (2025) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13822 · Cited by 4
“…including serotonin reuptake inhibitors and bupropion, indicate that the risk of switch during an acute treatment trial is less than 10% when antidepressants are combined with mood stabilizers, a rate that is comparable to or lower than those found in placebo control conditions [11, 12].”
Treatment of Depressive Episodes
Herrero, A., & Grande, I. (2025) · Springer eBooks · doi:10.1007/978-3-031-85519-1_22
Approche dimensionnelle des troubles bipolaires
Carrillo, P., Vinckier, F., & Henry, C. (2023) · Elsevier eBooks · doi:10.1016/b978-2-294-77180-4.00041-x
مبروک, ر. م. (2025) · مجلة كلية التربية جامعة بنها · doi:10.21608/jfeb.2025.402622.2192
Tricyclic antidepressants for treatment-resistant depression
Bobo, W. V., & Richelson, E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00008-6 · Cited by 4
Sabancı, B., Karaçiçek, G., & Çalışır, M. (2025) · European Archives of Social Sciences · doi:10.35365/eass.25.02.07
Liu, Q., Srivastava, P., Rozhkov, I., Farnum, G. A., Holmes, M. J., Fritsche, L. G., Belmonte, D. C., Ade, A. S., Sun, J., Yocum, A. K., et al. (2025) · medRxiv · doi:10.1101/2025.09.06.25335235 · Cited by 1
“If antidepressants are used in BP1, clinical guidelines advise co-prescription with a mood-stabilizing agent because of potential mood switching, although estimates of switch risk vary across studies (Melhuish Beaupre et al., 2020; Pacchiarotti et al., 2013; Sachs et al., 2007).”
Overview of Management Options
Vieta, E. (2013) · doi:10.1007/978-1-908517-94-4_6
Clock genes and biological rhythms. Effects of psychotropic drugs
Osland, T. M. (2012) · NORA - Norwegian Open Research Archives
Scott, J. L., Bentall, R. P., Kinderman, P., & Morriss, R. K. (2022) · Figshare · doi:10.6084/m9.figshare.19696008
Ravin, L., Edwards, C., & Lin, A. (2026) · Community Mental Health Journal · doi:10.1007/s10597-026-01742-2
Multi-nuclear RMN in Spectroscopy and Imagery at very high magnetic fields
Stout, J. A. (2019) · theses.fr (ABES) · doi:10.70675/e54ad71az8f87z4c42z9f45z1ddc59f3aac1
Mood Stabilizers Are the First Line of Treatment for Bipolar Disorder
Shah, S. R., Ibrahim, K., Sadah, A., & El‐Mallakh, R. S. (2026) · Southern Medical Journal · doi:10.14423/smj.0000000000001959
de Filippis, R., & Foysal, A. A. (2026) · OALib · doi:10.4236/oalib.1115136
Fornaro, M., Lorenzo, C. D., Oliva, V., Prisco, M. D., & Vieta, E. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122160 · Cited by 4
Serretti, A. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111854
Unipolar Depression and Bipolar Depression
Chang, S. M., & Sohn, I. (2026) · Springer eBooks · doi:10.1007/978-981-92-1331-3_1
Pros and Cons: The Usefulness of Antidepressants in Bipolar Depressive Episodes
Seo, J. S., & Lee, K. (2026) · Springer eBooks · doi:10.1007/978-981-92-1323-8_13
Schwartz, E. R., Sabbag, S. A., Buford, U., Kieffer, L., & Allespach, H. H. (2026) · Springer eBooks · doi:10.1007/978-1-4939-0779-3_33-4
de Filippis, R., & Foysal, A. A. (2026) · OALib · doi:10.4236/oalib.1115677
de Filippis, R., & Foysal, A. A. (2026) · OALib · doi:10.4236/oalib.1115674
Liu, K.-W., Bai, Y., Li, C., Tsai, S., Lin, W.-C., Chen, T.-J., & Chen, M. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122491
de Filippis, R., & Foysal, A. A. (2026) · OALib · doi:10.4236/oalib.1115675
Гоглов, И. (2026) · Journal of Bioinformatics and Genomics · doi:10.60797/jbg.2026.33.6
Exact gene overlap between the strict BD mapping set and quantitative Tier 1 targets
Гоглов, И. (2026) · Cifra LLC Journals · doi:10.60797/jbg.2026.33.6.4
Pathway enrichment across BD mapping and drug-evidence layers
Гоглов, И. (2026) · Cifra LLC Journals · doi:10.60797/jbg.2026.33.6.5
Ranked candidate evidence assessment
Гоглов, И. (2026) · Cifra LLC Journals · doi:10.60797/jbg.2026.33.6.3
Drug classes and representative molecular target categories included in the analysis
Гоглов, И. (2026) · Cifra LLC Journals · doi:10.60797/jbg.2026.33.6.2
Key genomic studies of bipolar disorder
Гоглов, И. (2026) · Cifra LLC Journals · doi:10.60797/jbg.2026.33.6.1
Primary g:Profiler enrichment by evidence layer
Гоглов, И. (2026) · Cifra LLC Journals · doi:10.60797/jbg.2026.33.6.6
Cross-layer evidence and calcium sensitivity analysis
Гоглов, И. (2026) · Cifra LLC Journals · doi:10.60797/jbg.2026.33.6.7
Serretti, A. (2026) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.70069
Metadata
- Authors
- Sachs, G. S., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Wisniewski, S. R., Gyulai, L., Friedman, E. S., Bowden, C. L., Fossey, M. D., Ostacher, M. J., Ketter, T. A., Patel, J., Hauser, P., Rapport, D., Martinez, J. M., Allen, M. H., Miklowitz, D. J., Otto, M. W., Dennehy, E. B., & Thase, M. E.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- University Hospitals Cleveland Medical Center (US)
- Baylor College of Medicine (US)
- University of Pittsburgh (US)
- University of Pennsylvania (US)
- The University of Texas at San Antonio Health Science Center (US)
- University of Oklahoma (US)
- Stanford Medicine (US)
- University of Massachusetts Chan Medical School (US)
- University of Toledo (US)
- University of Colorado Boulder (US)
- Boston University (US)
- Purdue University West Lafayette (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-04-26
- Volume
- 356
- Issue
- 17
- Pages
- 1711-1722
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2166423384
- Semantic Scholar
- c224a40d0ffd6471e7b72b38060d169ba1cdec34
- Cited by
- 937
- References
- 27
- Citations by year
- 2026: 16 · 2025: 16 · 2024: 33 · 2023: 17 · 2022: 15 · 2021: 68 · 2020: 33 · 2019: 29 · 2018: 36 · 2017: 28 · 2016: 53 · 2015: 47 · 2014: 51 · 2013: 52 · 2012: 61
- FWCI
- 56.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01mh80001-12-0-0)
- National Institute of Mental Health (N01-MH80001)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- bipolar depression, adjunctive antidepressant therapy, mood stabilizers, euthymia, bipolar disorder, antidepressant safety
- MeSH terms
- Adult, Bipolar Disorder, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Bupropion, Treatment Outcome, Paroxetine, Antidepressive Agents, Second-Generation, Antimanic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.